Page last updated: 2024-11-06

mitomycin and Esophageal Diseases

mitomycin has been researched along with Esophageal Diseases in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Esophageal Diseases: Pathological processes in the ESOPHAGUS.

Research Excerpts

ExcerptRelevanceReference
"7 % high dose), while both TGF-β3 dosage groups showed no significant change (65."1.40Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures. ( Chak, A; Cipriano, C; Lash, RH; Marks, JM; Ponsky, JL; Schomisch, SJ; Wu, Y, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, Y1
Schomisch, SJ1
Cipriano, C1
Chak, A1
Lash, RH1
Ponsky, JL1
Marks, JM1

Other Studies

1 other study available for mitomycin and Esophageal Diseases

ArticleYear
Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.
    Surgical endoscopy, 2014, Volume: 28, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Cicatrix; Disease Models, Animal; Dissection; Drug Therapy, Combin

2014